Vladislav Derkach
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Vladislav Derkach has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Mariia Gordienko
D.I. Mendeleyev University of Chemical Technology; 9, building 1, Miusskaya Ploshchad, Moscow, 125047, Russian Federation
3 shared publications - Anastasia A. Uvarova
Department of Chemical and Pharmaceutical Engineering, Mendeleev University of Chemical Technology of Russia, Moscow, Russia
1 shared publication - Elizaveta Mokhova
The Department of Chemical and Pharmaceutical Engineering, Mendeleev University of Chemical Technology of Russia (MUCTR), Moscow 125047, Russia
1 shared publication M. Klimenko
D.I. Mendeleyev University of Chemical Technology; 9, building 1, Miusskaya Ploshchad, Moscow, 125047, Russian Federation
1 shared publication- Natalia Menshutina
The Department of Chemical and Pharmaceutical Engineering, Mendeleev University of Chemical Technology of Russia (MUCTR), Moscow 125047, Russia
1 shared publication
Latest Publications
- 20 December 2025
- Published by Russian Vrach, Publishing House Ltd. in Problems of Biological, Medical and Pharmaceutical Chemistry
- p. 28
DEVELOPMENT OF A THERMO-SENSITIVE IN SITU NASAL GEL WITH NANOPARTICLES OF POLY(LACTIC-CO-GLYCOLIC) ACID COPOLYMER CONTAINING FAVIPIRAVIR
Introduction. Favipiravir is a selective inhibitor of viral RNA polymerase with a broad spectrum of antiviral activity; however, its low aqueous solubility results in reduced oral bioavailability. Therefore, the development of new delivery systems, such as thermosensitive nasal in situ gels, is necessary. The purpose of the work. To develop and characterize thermosensitive in situ gels based on P407 and P188 for intranasal delivery. Material and methods. Favipiravir-loaded PLGA nanoparticles were prepared using nanoprecipitation. Particle diameter was determined using dy-namic light scattering (DLS) at 25 °C. Thermosensitive gels were prepared using the cold method with varying P407 concentrations and varying the P407/P188 ratio. Rheological properties were measured using a SmartPave 102 rheometer at 10–40 °C and a heating rate of 0.05 °C/sec. In vitro re-lease studies were conducted using a DHC-6T transdermal diffusion tester in phosphate buffer, pH 6.4, at 37 °C, with samples analyzed at six time points using UV spectrophotometry. Results. The average diameter of favipiravir-loaded PLGA nanoparticles was 168.14±3.49 nm, a suitable size for intranasal delivery via the nose-to-brain mechanism. In situ temperature-sensitive gel studies revealed that as the P407 concentration increased from 18 to 25% by weight, the Tsol-gel decreased from 29.04±0.63 °C to 21.84±0.19 °C. The addition of P188 at an 8/2 ratio (P407/P188) significantly increased the T in the sol-gel by 6.64–8.38 °C compared to systems without P188. The favipiravir release profile from the API suspension was characterized by rapid release (46% in 5 min, 72% in 10 min); from PLGA nanoparticles, by delayed release (17–29% in 5–10 min, 94% in 120 min); and from the in situ gel with nanoparticles, by the most prolonged release (3–9% in 5–10 min, 65% in 120 min). Conclusion. An intranasal delivery system consisting of PLGA nanoparticles loaded with favipiravir in a thermosensitive in situ gel matrix based on P407 and P188 was developed. A dual release control mechanism (polymer degradation and delayed diffusion from the gel matrix) provides a pro-nounced prolonged effect.
- 20 December 2025
- Published by Russian Vrach, Publishing House Ltd. in Problems of Biological, Medical and Pharmaceutical Chemistry
- p. 28
DEVELOPMENT OF A THERMO-SENSITIVE IN SITU NASAL GEL WITH NANOPARTICLES OF POLY(LACTIC-CO-GLYCOLIC) ACID COPOLYMER CONTAINING FAVIPIRAVIR
Introduction. Favipiravir is a selective inhibitor of viral RNA polymerase with a broad spectrum of antiviral activity; however, its low aqueous solubility results in reduced oral bioavailability. Therefore, the development of new delivery systems, such as thermosensitive nasal in situ gels, is necessary. The purpose of the work. To develop and characterize thermosensitive in situ gels based on P407 and P188 for intranasal delivery. Material and methods. Favipiravir-loaded PLGA nanoparticles were prepared using nanoprecipitation. Particle diameter was determined using dy-namic light scattering (DLS) at 25 °C. Thermosensitive gels were prepared using the cold method with varying P407 concentrations and varying the P407/P188 ratio. Rheological properties were measured using a SmartPave 102 rheometer at 10–40 °C and a heating rate of 0.05 °C/sec. In vitro re-lease studies were conducted using a DHC-6T transdermal diffusion tester in phosphate buffer, pH 6.4, at 37 °C, with samples analyzed at six time points using UV spectrophotometry. Results. The average diameter of favipiravir-loaded PLGA nanoparticles was 168.14±3.49 nm, a suitable size for intranasal delivery via the nose-to-brain mechanism. In situ temperature-sensitive gel studies revealed that as the P407 concentration increased from 18 to 25% by weight, the Tsol-gel decreased from 29.04±0.63 °C to 21.84±0.19 °C. The addition of P188 at an 8/2 ratio (P407/P188) significantly increased the T in the sol-gel by 6.64–8.38 °C compared to systems without P188. The favipiravir release profile from the API suspension was characterized by rapid release (46% in 5 min, 72% in 10 min); from PLGA nanoparticles, by delayed release (17–29% in 5–10 min, 94% in 120 min); and from the in situ gel with nanoparticles, by the most prolonged release (3–9% in 5–10 min, 65% in 120 min). Conclusion. An intranasal delivery system consisting of PLGA nanoparticles loaded with favipiravir in a thermosensitive in situ gel matrix based on P407 and P188 was developed. A dual release control mechanism (polymer degradation and delayed diffusion from the gel matrix) provides a pro-nounced prolonged effect.
- 20 December 2025
- Published by Russian Vrach, Publishing House Ltd. in Problems of Biological, Medical and Pharmaceutical Chemistry
- p. 36
Нажмите на эту строку чтобы перейти к Новостям сайта "Русский врач" Click to go to the English version of the site" Перейти на сайт журнала "Врач" Перейти на сайт журнала "Медицинская сестра" Перейти на сайт журнала "Фармация" Перейти на сайт журнала "Молекулярная медицина" Перейти на сайт журнала "Вопросы биологической, медицинской и фармацевтической химии" Журнал включен в российские и международные библиотечные и реферативные базы данных < ВАК (Россия) РИНЦ (Россия) Эко-Вектор (Россия) DEVELOPMENT OF THE COMPOSITION OF THE DRY NASAL SPRAY VINPOCETINE AND THE TECHNOLOGY OF ITS PRODUCTION
Introduction. Vinpocetine has neuroprotective properties and is used to improve cognitive function; however, poor solubility and low bioavailability may limit its use. The development of a dry nasal spray vinpocetine with increased solubility is a topical issue. Aim of the study was to develop the composition of a prototype dry nasal spray of vinpocetine and the technology for its production. Material and Methods. The prototypes contained chitosan and synthesized poly-β-cyclodextrin. The formation of host-guest inclusion complexes by co-dissolution and co-attrition methods increased vinpocetine solubility. IR spectroscopy and X-ray diffraction analysis were used to confirm the formation of inclusion complexes and evaluate the sample properties. Spray drying was the final step in the formation of the dry nasal spray. The stability and mass (volume) uniformity of doses taken from a multi-dose package, dosing in a dry powder dispenser, and in vitro permeability in a transdermal diffusion tester were studied for the lead formulation. Results. Comparative studies of the developed samples with different vinpocetine:polycyclodextrin ratios were conducted. No significant differences in inclusion complex formation were demonstrated by the two methods. Therefore, the co-dissolution method was chosen as the preferred method for producing dry nasal spray prototype samples, as it is technologically simpler. In vitro permeation results showed that most of the vinpocetine dissolves and penetrates the membrane within 30 minutes. Dosage uniformity and stability of the developed prototypes for 12 months were demonstrated. Conclusions. The experimental studies demonstrate the feasibility of using powder particles containing the vinpocetine-polycyclodextrin inclusion complex and chitosan, obtained by spray drying, as prototypes for a dry nasal spray for vinpocetine.
- 20 December 2025
- Published by Russian Vrach, Publishing House Ltd. in Problems of Biological, Medical and Pharmaceutical Chemistry
- p. 36
Нажмите на эту строку чтобы перейти к Новостям сайта "Русский врач" Click to go to the English version of the site" Перейти на сайт журнала "Врач" Перейти на сайт журнала "Медицинская сестра" Перейти на сайт журнала "Фармация" Перейти на сайт журнала "Молекулярная медицина" Перейти на сайт журнала "Вопросы биологической, медицинской и фармацевтической химии" Журнал включен в российские и международные библиотечные и реферативные базы данных < ВАК (Россия) РИНЦ (Россия) Эко-Вектор (Россия) DEVELOPMENT OF THE COMPOSITION OF THE DRY NASAL SPRAY VINPOCETINE AND THE TECHNOLOGY OF ITS PRODUCTION
Introduction. Vinpocetine has neuroprotective properties and is used to improve cognitive function; however, poor solubility and low bioavailability may limit its use. The development of a dry nasal spray vinpocetine with increased solubility is a topical issue. Aim of the study was to develop the composition of a prototype dry nasal spray of vinpocetine and the technology for its production. Material and Methods. The prototypes contained chitosan and synthesized poly-β-cyclodextrin. The formation of host-guest inclusion complexes by co-dissolution and co-attrition methods increased vinpocetine solubility. IR spectroscopy and X-ray diffraction analysis were used to confirm the formation of inclusion complexes and evaluate the sample properties. Spray drying was the final step in the formation of the dry nasal spray. The stability and mass (volume) uniformity of doses taken from a multi-dose package, dosing in a dry powder dispenser, and in vitro permeability in a transdermal diffusion tester were studied for the lead formulation. Results. Comparative studies of the developed samples with different vinpocetine:polycyclodextrin ratios were conducted. No significant differences in inclusion complex formation were demonstrated by the two methods. Therefore, the co-dissolution method was chosen as the preferred method for producing dry nasal spray prototype samples, as it is technologically simpler. In vitro permeation results showed that most of the vinpocetine dissolves and penetrates the membrane within 30 minutes. Dosage uniformity and stability of the developed prototypes for 12 months were demonstrated. Conclusions. The experimental studies demonstrate the feasibility of using powder particles containing the vinpocetine-polycyclodextrin inclusion complex and chitosan, obtained by spray drying, as prototypes for a dry nasal spray for vinpocetine.
- Open Access
Investigation of Rheological Characteristics of Thermosensitive Nasal In Situ Gels Based on P407 and Their Effect on Spray Pattern
This article presents the results of a study on the rheological characteristics of in situ thermosensitive nasal gels based on poloxamer 407 (P407) and their effect on spray angle. The development of new drug delivery systems based on in situ thermosensitive gels can overcome several shortcomings of traditional nasal sprays associated with mucociliary clearance and low mucoadhesion. Using the cold method, samples based on P407 were prepared in pure form, in combination with poloxamer 188 (P188), and with the addition of several mucoadhesive polymers: chitosan, sodium alginate, and hydroxypropyl methylcellulose (HPMC). Analytical studies were carried out for all obtained samples, which showed that the gelling temperature (Tsol–gel) of compositions with P407 was inversely dependent on its concentration, decreasing from 32.71 °C to 24.63 °C. The addition of hydrophilic P188 increased Tsol–gel. The addition of mucoadhesive polymers had varying effects on Tsol–gel: chitosan and HPMC increased the temperature, while sodium alginate decreased it. The addition of mucoadhesive polymers significantly affected the viscosity of the formulations; for example, the addition of sodium alginate resulted in a fivefold increase, making the formulations unsuitable for spraying. A study of the spray angles of Tsol–gel samples in the range of 27–31 °C using the SprayVIEW measuring system revealed an inverse relationship between the viscosity of the formulations and the spray angle. A mathematical model of the solution droplet trajectory was presented, enabling the spray angle to be predicted depending on the formulation composition. The relative error of the computational experiments did not exceed 10%. This approach has the potential to reduce the number of full-scale experiments, and consequently their cost.
Open AccessInvestigation of Rheological Characteristics of Thermosensitive Nasal In Situ Gels Based on P407 and Their Effect on Spray Pattern
This article presents the results of a study on the rheological characteristics of in situ thermosensitive nasal gels based on poloxamer 407 (P407) and their effect on spray angle. The development of new drug delivery systems based on in situ thermosensitive gels can overcome several shortcomings of traditional nasal sprays associated with mucociliary clearance and low mucoadhesion. Using the cold method, samples based on P407 were prepared in pure form, in combination with poloxamer 188 (P188), and with the addition of several mucoadhesive polymers: chitosan, sodium alginate, and hydroxypropyl methylcellulose (HPMC). Analytical studies were carried out for all obtained samples, which showed that the gelling temperature (Tsol–gel) of compositions with P407 was inversely dependent on its concentration, decreasing from 32.71 °C to 24.63 °C. The addition of hydrophilic P188 increased Tsol–gel. The addition of mucoadhesive polymers had varying effects on Tsol–gel: chitosan and HPMC increased the temperature, while sodium alginate decreased it. The addition of mucoadhesive polymers significantly affected the viscosity of the formulations; for example, the addition of sodium alginate resulted in a fivefold increase, making the formulations unsuitable for spraying. A study of the spray angles of Tsol–gel samples in the range of 27–31 °C using the SprayVIEW measuring system revealed an inverse relationship between the viscosity of the formulations and the spray angle. A mathematical model of the solution droplet trajectory was presented, enabling the spray angle to be predicted depending on the formulation composition. The relative error of the computational experiments did not exceed 10%. This approach has the potential to reduce the number of full-scale experiments, and consequently their cost.